Restaurants, money hurt diabetes control
Posted on: Friday, 20 March 2009, 17:35 CDT
Eating out, lack of social support and high-risk lifestyles are barriers to good type 2 diabetes control, researchers in Hong Kong and Northern Ireland said.
A review of some 8,900 insured patients and 4,550 healthcare providers in 28 countries was conducted by researchers from Hong Kong and Northern Ireland.
The study, published in the March issue of the Journal of Nursing and Healthcare of Chronic Illness, shows that psychosocial, socioeconomic, physical, environmental and cultural factors can provide major barriers to effective care.
Diabetes is a chronic condition and patients need to modify their lifestyle on a long-term basis to cope with it,
Sandra Pun of the School of Nursing at The Hong Kong Polytechnic University said in a statement.
Major barriers identified by the review included:
-- Financial. Even if healthcare was free or funded by insurance, patients still had to spend more money on healthy food, home glucose monitoring kits and transport to and from healthcare appointments.
-- Social support. Patients who received support from family, friends and diabetes clinics appeared to handle self-care better than those who did not.
-- Eating out in restaurants and being denied favorite food were frequently mentioned problem.
-- Exercise. Attitudes toward exercise, physical limitations and discomfort prevented people from taking regular exercise.
-- High-risk lifestyles. Behavioral and psychiatric disorders and cultural and language barriers, among both patients and family members.
-- Some patients forgot to take their medication and others ran out.
Source: United Press International
Related Articles
- Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes
- Low Blood Sugar Events Increase Dementia Risk in Elderly Patients With Type 2 Diabetes, Kaiser Permanente Study Finds
- Hypoglycemia barrier to diabetic exercise
- Isis Pharmaceuticals Reports Positive Phase 2 Data: ISIS 113715 Improves Glucose Control in Patients With Type 2 Diabetes
- Motion Picture & Television Fund Ranks Highest in Southern California in Statewide Consumer Survey of Patients, Quality Healthcare
- Metabolic Syndrome Accompanied By Hypercholesterolemia Is Strongly Associated With Proinflammatory State and Impairment of Fibrinolysis in Patients With Type 2 Diabetes: Synergistic Effects of Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fib
- New Analysis in Patients With Type 2 Diabetes From Trial With VYTORIN-TM- -Ezetimibe/Simvastatin- Presented at ADA; Consistent With Overall Study Which Showed Superior LDL Cholesterol Reduction With VYTORIN Versus Lipitor
- Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea
- Stimulation of Insulin Secretion By Intravenous Bolus Injection and Continuous Infusion of Gastric Inhibitory Polypeptide in Patients With Type 2 Diabetes and Healthy Control Subjects
- Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes
User Comments (0)

RSS Feeds